This topic contains a solution. Click here to go to the answer

Author Question: In research studies that compare different groups of individuals for each of the treatment ... (Read 191 times)

humphriesbr@me.com

  • Hero Member
  • *****
  • Posts: 550
In research studies that compare different groups of individuals for each of the treatment conditions, ____ is a threat to internal validity.
 
  a. time
 b. assignment bias
  c. novelty
 d. sensitivity

Question 2

The complex dynamic iterative process in which the development of a theory and the collection of data related to that theory build on each other is referred to as _______________.
 
  Fill in the blank(s) with correct word



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

jaaaaaaa

  • Sr. Member
  • ****
  • Posts: 341
Answer to Question 1

b

Answer to Question 2

grounded theory




humphriesbr@me.com

  • Member
  • Posts: 550
Reply 2 on: Jun 19, 2018
YES! Correct, THANKS for helping me on my review


dantucker

  • Member
  • Posts: 346
Reply 3 on: Yesterday
:D TYSM

 

Did you know?

When blood is deoxygenated and flowing back to the heart through the veins, it is dark reddish-blue in color. Blood in the arteries that is oxygenated and flowing out to the body is bright red. Whereas arterial blood comes out in spurts, venous blood flows.

Did you know?

Your chance of developing a kidney stone is 1 in 10. In recent years, approximately 3.7 million people in the United States were diagnosed with a kidney disease.

Did you know?

Children with strabismus (crossed eyes) can be treated. They are not able to outgrow this condition on their own, but with help, it can be more easily corrected at a younger age. It is important for infants to have eye examinations as early as possible in their development and then another at age 2 years.

Did you know?

Asthma cases in Americans are about 75% higher today than they were in 1980.

Did you know?

The first oral chemotherapy drug for colon cancer was approved by FDA in 2001.

For a complete list of videos, visit our video library